Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
This report elaborates on the current development of the Therapeutic Nuclear Medicines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Lantheus
Novartis AG
Q BioMed
Dongcheng
Jubilant DraxImage
Progenics Pharmaceuticals
Spectrum Pharmaceuticals
Bayer
International Isotopes
Curium Pharmaceuticals
China Isotope & Radiation
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Radium-223
Lutetium-177
Iodine-131
Other
Application:
Thyroid
Bone Metastasis
Lymphoma
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Therapeutic Nuclear Medicines Industry Overview
-
1.1.1 Therapeutic Nuclear Medicines Market Scope and Market Segments
-
1.1.2 Therapeutic Nuclear Medicines Industry Characteristics
-
1.1.3 Global and China Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Therapeutic Nuclear Medicines Production Value and Growth Rate (2017-2028)
-
1.2 Global Therapeutic Nuclear Medicines Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Radium-223
-
1.2.2 Lutetium-177
-
1.2.3 Iodine-131
-
1.2.4 Other
-
1.3 Global Therapeutic Nuclear Medicines Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Thyroid
-
1.3.2 Bone Metastasis
-
1.3.3 Lymphoma
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Therapeutic Nuclear Medicines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Therapeutic Nuclear Medicines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Therapeutic Nuclear Medicines Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Therapeutic Nuclear Medicines Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Therapeutic Nuclear Medicines Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Therapeutic Nuclear Medicines Industry Porter's Five Forces Model Analysis
-
2.2.3 Therapeutic Nuclear Medicines Industry PEST Analysis
-
2.3 Therapeutic Nuclear Medicines Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Therapeutic Nuclear Medicines Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Therapeutic Nuclear Medicines Industry
Chapter 3 Global and China Therapeutic Nuclear Medicines Market, by Manufacturer
-
3.1 Global and China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Therapeutic Nuclear Medicines Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Therapeutic Nuclear Medicines Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Therapeutic Nuclear Medicines Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Therapeutic Nuclear Medicines Market Top 3 Players
Chapter 4 Global and China Therapeutic Nuclear Medicines Market, by Type (2017-2028)
-
4.1 Therapeutic Nuclear Medicines Market Trend, by Type
-
4.2 Global Therapeutic Nuclear Medicines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Therapeutic Nuclear Medicines Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Therapeutic Nuclear Medicines Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Therapeutic Nuclear Medicines Price Trend, by Type (2017-2028)
-
4.3 China Therapeutic Nuclear Medicines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Therapeutic Nuclear Medicines Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Therapeutic Nuclear Medicines Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Therapeutic Nuclear Medicines Price Trend, by Type (2017-2028)
Chapter 5 Global and China Therapeutic Nuclear Medicines Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Therapeutic Nuclear Medicines Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Therapeutic Nuclear Medicines Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Therapeutic Nuclear Medicines Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Therapeutic Nuclear Medicines Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Therapeutic Nuclear Medicines Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Therapeutic Nuclear Medicines Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Therapeutic Nuclear Medicines Market Analysis
-
7.1 North America Therapeutic Nuclear Medicines Market, by Type
-
7.2 North America Therapeutic Nuclear Medicines Market, by Application
-
7.3 North America Therapeutic Nuclear Medicines Market Analysis and Forecast, by Country
-
7.3.1 United States Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Therapeutic Nuclear Medicines Market Analysis
-
8.1 Europe Therapeutic Nuclear Medicines Market, by Type
-
8.2 Europe Therapeutic Nuclear Medicines Market, by Application
-
8.3 Europe Therapeutic Nuclear Medicines Market Analysis and Forecast, by Country
-
8.3.1 Germany Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Therapeutic Nuclear Medicines Market Analysis
-
9.1 APAC Therapeutic Nuclear Medicines Market, by Type
-
9.2 APAC Therapeutic Nuclear Medicines Market, by Application
-
9.3 APAC Therapeutic Nuclear Medicines Market Analysis and Forecast, by Country
-
9.3.1 China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Therapeutic Nuclear Medicines Market Analysis
-
10.1 Latin America, Middle East and Africa Therapeutic Nuclear Medicines Market, by Type
-
10.2 Latin America, Middle East and Africa Therapeutic Nuclear Medicines Market, by Application
-
10.3 Latin America, Middle East and Africa Therapeutic Nuclear Medicines Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Therapeutic Nuclear Medicines Company Profiles
-
11.1 Lantheus
-
11.1.1 Lantheus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Lantheus Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.1.3 Lantheus Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Novartis AG
-
11.2.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Novartis AG Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.2.3 Novartis AG Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Q BioMed
-
11.3.1 Q BioMed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Q BioMed Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.3.3 Q BioMed Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Dongcheng
-
11.4.1 Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Dongcheng Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.4.3 Dongcheng Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Jubilant DraxImage
-
11.5.1 Jubilant DraxImage Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.5.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Progenics Pharmaceuticals
-
11.6.1 Progenics Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.6.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Spectrum Pharmaceuticals
-
11.7.1 Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.7.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Bayer
-
11.8.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Bayer Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.8.3 Bayer Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 International Isotopes
-
11.9.1 International Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 International Isotopes Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.9.3 International Isotopes Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Curium Pharmaceuticals
-
11.10.1 Curium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.10.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 China Isotope & Radiation
-
11.11.1 China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Profiles, Application and Specification
-
11.11.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Therapeutic Nuclear Medicines Industry Investment Prospect and Risk Assessment
-
12.1 Therapeutic Nuclear Medicines Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Therapeutic Nuclear Medicines Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Production Value and Growth Rate (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Production Value and Growth Rate (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Radium-223 (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Lutetium-177 (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Iodine-131 (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Thyroid (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Bone Metastasis (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Lymphoma (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Therapeutic Nuclear Medicines Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Therapeutic Nuclear Medicines Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Therapeutic Nuclear Medicines Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Therapeutic Nuclear Medicines Market Share, by Manufacturer in 2021
-
Figure Global and China Therapeutic Nuclear Medicines Market Share, by Manufacturer in 2022
-
Table Global Therapeutic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Sales Value, by Type (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Sales Value Share, by Type (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Price Trend, by Type (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Value, by Type (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Value Share, by Type (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Price Trend, by Type (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Sales Value, by Application (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Figure Global Therapeutic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Value, by Application (2017-2028)
-
Table China Therapeutic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure North America Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Therapeutic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Table North America Therapeutic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table North America Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure North America Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table North America Therapeutic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table North America Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure North America Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure United States Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure United States Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Canada Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table Europe Therapeutic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table Europe Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure Europe Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table Europe Therapeutic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table Europe Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Europe Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Germany Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure UK Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure UK Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure France Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure France Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Italy Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Spain Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Poland Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Russia Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table APAC Therapeutic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table APAC Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure APAC Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table APAC Therapeutic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table APAC Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure APAC Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure China Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Japan Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure India Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure India Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Therapeutic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Therapeutic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Therapeutic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Therapeutic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Therapeutic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table Lantheus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lantheus Product Profiles, Application and Specification
-
Table Lantheus Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis AG Product Profiles, Application and Specification
-
Table Novartis AG Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Q BioMed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Q BioMed Product Profiles, Application and Specification
-
Table Q BioMed Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dongcheng Product Profiles, Application and Specification
-
Table Dongcheng Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Jubilant DraxImage Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Jubilant DraxImage Product Profiles, Application and Specification
-
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Progenics Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Progenics Pharmaceuticals Product Profiles, Application and Specification
-
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Spectrum Pharmaceuticals Product Profiles, Application and Specification
-
Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table International Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table International Isotopes Product Profiles, Application and Specification
-
Table International Isotopes Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Curium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Curium Pharmaceuticals Product Profiles, Application and Specification
-
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table China Isotope & Radiation Product Profiles, Application and Specification
-
Table China Isotope & Radiation Therapeutic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
